About Khiron Life Sciences Corp

Founded in October 2019, working assiduously to provide best care possible to patients in the UK. That is why our primary goal is to facilitate access to high-quality cannabis-based pharmaceutical products.

Khiron Life Sciences UK was founded in October 2019 and has been working assiduously to provide best care possible to patients in the UK. That is why our primary goal is to facilitate access to high-quality cannabis-based pharmaceutical products.

Putting our patients first is what allowed Khiron Life Sciences to become the medical cannabis market leader in Latin America.

Our team is composed of experienced professionals from of the European medical cannabis industry. We are working closely with the London-based leading independent scientific body, Drug Science, responsible for Project Twenty21, the largest medical cannabis patient registry in Europe.